Your browser doesn't support javascript.
COVID-19 Outbreak: Pathogenesis, Current Therapies, and Potentials for Future Management.
Hossain, Md Farhad; Hasana, Sharifa; Mamun, Abdullah Al; Uddin, Md Sahab; Wahed, Mir Imam Ibne; Sarker, Sabarni; Behl, Tapan; Ullah, Irfan; Begum, Yesmin; Bulbul, Israt Jahan; Amran, Md Shah; Rahman, Md Habibur; Bin-Jumah, May N; Alkahtani, Saad; Mousa, Shaker A; Aleya, Lotfi; Abdel-Daim, Mohamed M.
  • Hossain MF; Department of Physical Therapy, Graduate School of Inje University, Gimhae, South Korea.
  • Hasana S; Pharmakon Neuroscience Research Network, Dhaka, Bangladesh.
  • Mamun AA; Department of Pharmacy, Southeast University, Dhaka, Bangladesh.
  • Uddin MS; Pharmakon Neuroscience Research Network, Dhaka, Bangladesh.
  • Wahed MII; Department of Pharmacy, Southeast University, Dhaka, Bangladesh.
  • Sarker S; Pharmakon Neuroscience Research Network, Dhaka, Bangladesh.
  • Behl T; Department of Pharmacy, Southeast University, Dhaka, Bangladesh.
  • Ullah I; Department of Pharmacy, Faculty of Science, University of Rajshahi, Rajshahi, Bangladesh.
  • Begum Y; Department of Pharmacy, Faculty of Life and Earth Sciences, Jagannath University, Dhaka, Bangladesh.
  • Bulbul IJ; Chitkara College of Pharmacy, Chitkara University, Punjab, India.
  • Amran MS; Kabir Medical College, Gandhara University, Peshawar, Pakistan.
  • Rahman MH; Department of Pharmacy, Southeast University, Dhaka, Bangladesh.
  • Bin-Jumah MN; Department of Pharmacy, Southeast University, Dhaka, Bangladesh.
  • Alkahtani S; Department of Pharmaceutical Chemistry, University of Dhaka, Dhaka, Bangladesh.
  • Mousa SA; Department of Global Medical Science, Yonsei University, Seoul, South Korea.
  • Aleya L; Department of Biology, College of Science, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia.
  • Abdel-Daim MM; Department of Zoology, College of Science, King Saud University, Riyadh, Saudi Arabia.
Front Pharmacol ; 11: 563478, 2020.
Article in English | MEDLINE | ID: covidwho-909021
ABSTRACT
At the end of 2019, a novel coronavirus (CoV) was found at the seafood market of Hubei province in Wuhan, China, and this virus was officially named coronavirus diseases 2019 (COVID-19) by World Health Organization (WHO). COVID-19 is mainly characterized by severe acute respiratory syndrome coronavirus-2 (SARS-CoV2) and creates public health concerns as well as significant threats to the economy around the world. Unfortunately, the pathogenesis of COVID-19 is unclear and there is no effective treatment of this newly life-threatening and devastating virus. Therefore, it is crucial to search for alternative methods that alleviate or inhibit the spread of COVID-19. In this review, we try to find out the etiology, epidemiology, symptoms as well as transmissions of this novel virus. We also summarize therapeutic interventions and suggest antiviral treatments, immune-enhancing candidates, general supplements, and CoV specific treatments that control replication and reproduction of SARS-CoV and Middle East respiratory syndrome coronavirus (MERS-CoV).
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Etiology study Language: English Journal: Front Pharmacol Year: 2020 Document Type: Article Affiliation country: Fphar.2020.563478

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Etiology study Language: English Journal: Front Pharmacol Year: 2020 Document Type: Article Affiliation country: Fphar.2020.563478